IDA is very excited to meet with participants in the Career Forums this year. IDA is the global leader in assisting innovative US and EU bio-pharmaceutical companies to develop business, regulatory and scientific strategies to enter the Japanese and Asian bio-pharmaceutical markets. We welcome the chance to discuss with you opportunities for developing a unique and challenging career in the global pharmaceutical industry.
Integrated Development Associates Co., Ltd. (IDA) is a subsidiary of Chiltern International, one of the largest pharmaceutical Contract Research Organizations in the world. Chiltern is focused on developing new drugs for all global markets and IDA is focused on assisting companies in planning and conducting clinical trials necessary to gain approval for these products in Japan and Asia. IDA almost exclusively works with US and European biopharmaceutical companies developing novel products addressing high unmet medical needs. IDA rightfully claims leadership within this business niche having taken a leading role in the development of cutting edge regenerative medicines and being the only foreign company and the only service company to be selected to receive SAKIGAKE designation, which is granted by the Japanese government to companies developing breakthrough medications which address diseases with particularly high unmet medical needs.
IDA seeks to help its clients develop strategies to best integrate Japan and Asia into global drug development which enhances the value of their products. Its team of highly experience drug development experts in Japan works closely with our parent company, Chiltern International, with over 5,000 employees in over 30 countries throughout the world.
IDA assists its clients with the planning and implementation of drug development in Japan and Asian through the following services: 1) Medical & Regulatory Strategy- Identifies the medical positioning of products and prepares regulatory and development strategies based on expert medical and scientific insight. 2) Management of Clinical Development- Plans and manages all aspects of drug development through a team of seasoned bilingual professionals with extensive global development experience. 3) Partnering Support & Risk-Sharing Development- Assists in planning and implementing commercialization through identification of and assistance in negotiations with potential licensing partners.
IDA assists its clients with the planning and implementation of drug development in Japan and Asian through the following services: 1) Medical & Regulatory Strategy- Identifies the medical positioning of products and prepares regulatory and development strategies based on expert medical and scientific insight. 2) Management of Clinical Development- Plans and manages all aspects of drug development through a team of seasoned bilingual professionals with extensive global development experience. 3) Partnering Support & Risk-Sharing Development- Assists in planning and implementing commercialization through identification of and assistance in negotiations with potential licensing partners.
IDA is part of Chiltern International which brings it access to many important global resources and expertise. However, it has retained its name and operates with a large degree of independence in order to retain the innovative focus on its specialty niche which is the development of novel products for the Japanese and Asian markets. We promote a culture which encourages employees to proactively take on new challenges and grow with the support of a team of experts who can provide insights and guidance.
IDA has access to the global training infrastructure of Chiltern International which provides resources to a large array of medical, technical and regulatory training program. IDA also has a dedicated Training Department that aims to ensure that employees have the appropriate training to conduct their work in a quality and efficient manner.
IDA has a very supportive management team. Likewise, the management caters to employees needs to ensure that they are being addressed.
IDA offers salary and benefits that are competitive with industry standards and commensurate with individual's background & qualifications.
IDA is a growing company and has a very dynamic work environment. Teams are encouraged to regularly discuss with managers and among themselves what are the challenges they are facing as the company grows and how to approach tasks as teams that allow for growth of individuals and the efficient operation of the team. Given the rapid growth of IDA both organically but also through its partnership with Chiltern, there are numerous paths for career growth not only in scientific, technical and clinical areas but also in business development, process management and licensing and partnering.
2004
Tokyo Office Akasaka Intercity 11F 1-11-44, Akasaka, Minato-ku Tokyo 107-0052 Tel: +81-3-6685-5191 Fax: +81-3-6685-5192
John Winebarger has nearly 30 years of experience related to Japanese & Asian drug development. He has extensive experience in assisting Japanese pharmaceutical companies in developing drug for the US/EU as well as supporting western companies to develop drugs for Japan & Asia. He established IDA in 2004 which has become a leader in supporting globally integrated drug development in Japan & Asia.
Osaka Office No.6 Shin-Osaka Building 9th Fl. 6-7-3 Nishinakajima, Yodogawa-ku, Osaka 532-0011 Japan Tel: +81-6-6195-7501 Fax: +81-6-6195-7502 Manila Office 2011-2012, 20th Floor, Entrata Urban Complex Condominium Corp. 2609 Civic Drive, Filinvest City, Alabang Muntinlupa City, Manila 1781 Philippines Tel: +63-2-777-3375 Fax: +63-2-777-3534
